Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicentre, Non-comparative, Open and Single Stage Study to Assess the Efficacy and Safety of Pamoate of Triptorelin 11.25 MG in Children With Precocious Puberty

NCT00564850 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00564850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00564850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicentre, Non-comparative, Open and Single Stage Study to Assess the Efficacy and Safety of Pamoate of Triptorelin 11.25 MG in Children With Precocious Puberty
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
October 31, 2010
Enrollment
37 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

precocious puberty